ATE405251T1 - Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung - Google Patents

Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung

Info

Publication number
ATE405251T1
ATE405251T1 AT01999357T AT01999357T ATE405251T1 AT E405251 T1 ATE405251 T1 AT E405251T1 AT 01999357 T AT01999357 T AT 01999357T AT 01999357 T AT01999357 T AT 01999357T AT E405251 T1 ATE405251 T1 AT E405251T1
Authority
AT
Austria
Prior art keywords
drug
compositions
composition
production
delayed release
Prior art date
Application number
AT01999357T
Other languages
English (en)
Inventor
Min-Hyo Seo
Yil-Woong Yi
Sang-Jun Lee
Jae-Hong Kim
Original Assignee
Samyang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Corp filed Critical Samyang Corp
Application granted granted Critical
Publication of ATE405251T1 publication Critical patent/ATE405251T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Steroid Compounds (AREA)
AT01999357T 2000-12-07 2001-12-07 Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung ATE405251T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20000074098 2000-12-07

Publications (1)

Publication Number Publication Date
ATE405251T1 true ATE405251T1 (de) 2008-09-15

Family

ID=19702771

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01999357T ATE405251T1 (de) 2000-12-07 2001-12-07 Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung

Country Status (10)

Country Link
US (1) US7153520B2 (de)
EP (1) EP1339389B1 (de)
JP (1) JP2004514734A (de)
KR (1) KR100446101B1 (de)
CN (1) CN1234416C (de)
AT (1) ATE405251T1 (de)
AU (2) AU2002222733B2 (de)
CA (1) CA2430481C (de)
DE (1) DE60135486D1 (de)
WO (1) WO2002045689A1 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US7498045B2 (en) * 2001-08-31 2009-03-03 Thomas M. S. Chang Biodegradable polymeric nanocapsules and uses thereof
EP1448707B1 (de) * 2001-10-18 2007-08-22 Samyang Corporation Polymermicellenzusammensetzung mit verbesserter stabilität
US7649023B2 (en) 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
CN1684663A (zh) 2002-07-31 2005-10-19 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
US8986737B2 (en) 2002-09-05 2015-03-24 Wm. Marsh Rice University Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
AU2003272284B2 (en) * 2002-09-05 2009-03-05 Catherine G. Ambrose Antibiotic microspheres for treatment of infections and osteomyelitis
WO2004035013A2 (en) * 2002-10-21 2004-04-29 L'oreal Process for dissolving lipophilic compounds, and cosmetic composition
EP1627645B1 (de) * 2003-05-26 2017-08-23 Hiroshi Maeda Antitumorales mittel und verfahren zu seiner herstellung
DK1635875T3 (da) * 2003-06-26 2009-01-12 Psivida Inc In-situ-geldannende lægemiddeladministrationssystem
JP5628467B2 (ja) 2003-06-26 2014-11-19 シヴィダ・ユーエス・インコーポレイテッドＰｓｉｖｉｄａ Ｕｓ， Ｉｎｃ． 生体分解性徐放性ドラッグデリバリーシステム
JP4939936B2 (ja) * 2003-06-27 2012-05-30 株式會社アモーレパシフィック 生理活性成分を含有する自己集合性高分子ナノ粒子の製造方法、及び得られた自己集合性高分子ナノ粒子を含有する外用剤組成物
CN100539988C (zh) * 2003-06-27 2009-09-16 株式会社太平洋 含有生理活性成分的自聚集聚合物纳米颗粒和含有该纳米颗粒的外用搽剂
KR101054728B1 (ko) 2004-06-16 2011-08-05 (주)아모레퍼시픽 난용성 발모 및 육모 생리활성 물질인 사이클로스포린을포함하는 나노입자 및 이를 함유하는 피부 외용제 조성물
WO2005000258A1 (en) * 2003-06-27 2005-01-06 Amorepacific Corporation Self-assembled polymeric nanoparticles containing physiologically active ingredients and external application containing the nanoparticles
KR100967113B1 (ko) 2003-12-03 2010-07-05 (주)아모레퍼시픽 코엔자임 ｑ10을 함유한 자기회합성 고분자 나노입자 및이를 함유한 피부 외용제 조성물
KR20050064075A (ko) * 2003-12-23 2005-06-29 주식회사 삼양사 이트라코나졸을 유효성분으로 하는 약학적 조성물
GB0412866D0 (en) * 2004-06-09 2004-07-14 Novartis Ag Organic compounds
US8980300B2 (en) 2004-08-05 2015-03-17 Advanced Cardiovascular Systems, Inc. Plasticizers for coating compositions
US20060034889A1 (en) * 2004-08-16 2006-02-16 Macromed, Inc. Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
EP1827395A2 (de) 2004-11-02 2007-09-05 Tel-Aviv University Future Technology Development L.P. Formulierungen von wasserunlöslichen oder schwer wasserlöslichen arzneimitteln in lipidierten glykosaminoglykanpartikeln, deren herstellung und deren verwendung zur diagnose und therapie
US7601796B2 (en) * 2005-01-04 2009-10-13 Intezyne Technologies, Inc. Synthesis of hybrid block copolymers and uses thereof
JP2007023023A (ja) * 2005-06-15 2007-02-01 Kanagawa Acad Of Sci & Technol 組織接着性薬剤放出ゲル形成用組成物
EP2063970A1 (de) * 2006-09-19 2009-06-03 FUJIFILM Manufacturing Europe B.V. Herstellung von feinen teilchen
WO2008035229A2 (en) * 2006-09-22 2008-03-27 Labopharm, Inc. Compositions and methods for ph targeted drug delivery
US20100008998A1 (en) * 2006-09-26 2010-01-14 Samyang Corporation Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
GB0714223D0 (en) * 2007-07-20 2007-08-29 Fujifilm Mfg Europe Bv Preparation of fine particles
GB0720716D0 (en) * 2007-10-23 2007-12-05 York Pharma Plc Novel formulation
US8642062B2 (en) * 2007-10-31 2014-02-04 Abbott Cardiovascular Systems Inc. Implantable device having a slow dissolving polymer
EP2219620B1 (de) * 2007-11-13 2017-07-19 Surmodics, Inc. Viskose terpolymere als arzneiabgabe-plattform
US9801818B2 (en) 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
CN101910246B (zh) 2007-12-31 2013-01-02 株式会社三养生物制药 包含源自α-羟酸的疏水嵌段的高纯两亲共聚物及其制备方法
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
WO2009091622A1 (en) 2008-01-18 2009-07-23 Dow Global Technologies Inc. Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol
EP2251006B1 (de) 2008-02-22 2017-07-19 Toray Industries, Inc. Mikropartikel und pharmazeutische zusammensetzungen daraus
US8858995B2 (en) * 2008-03-10 2014-10-14 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents
EP2103313A1 (de) * 2008-03-19 2009-09-23 Koninklijke Philips Electronics N.V. Verfahren für die Synthese von Hohlkugeln
TWI388591B (zh) * 2008-03-28 2013-03-11 Ind Tech Res Inst 溫度敏感性材料
US8916188B2 (en) 2008-04-18 2014-12-23 Abbott Cardiovascular Systems Inc. Block copolymer comprising at least one polyester block and a poly (ethylene glycol) block
EA020954B1 (ru) 2008-06-16 2015-03-31 Бинд Терапьютикс, Инк. Загруженные лекарственным средством полимерные наночастицы, фармацевтическая композиция и способ лечения рака
US8318211B2 (en) 2008-06-16 2012-11-27 Bind Biosciences, Inc. Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
WO2010005726A2 (en) 2008-06-16 2010-01-14 Bind Biosciences Inc. Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
RU2504360C2 (ru) 2008-08-12 2014-01-20 Новартис Аг Фармацевтические композиции
EP2172189A1 (de) * 2008-10-01 2010-04-07 Novartis AG Pharmazeutische Zusammensetzungen
JP2010065067A (ja) * 2008-09-08 2010-03-25 Tokyo Univ Of Agriculture & Technology 粒子およびその製造方法、ならびにゲル
BRPI0913697A2 (pt) * 2008-09-25 2016-10-11 Invivo Therapeutics Corp lesão de medula, inflamação e doença auto-imuni: agentes teraupêuticos de liberação local controlada.
TWI372057B (en) * 2008-12-11 2012-09-11 Dev Center Biotechnology Sustained release implant for granisetron
MX2011006265A (es) * 2008-12-11 2012-06-28 A P Pharma Inc Metodos para mejorar la estabilidad de poliortoesteres y sus formulaciones.
JP2012512175A (ja) 2008-12-15 2012-05-31 バインド バイオサイエンシズ インコーポレイテッド 治療薬を徐放するための長時間循環性ナノ粒子
US9480643B2 (en) * 2008-12-23 2016-11-01 Surmodics Pharmaceuticals, Inc. Implantable composites and implants comprising same
US8974808B2 (en) 2008-12-23 2015-03-10 Surmodics, Inc. Elastic implantable composites and implants comprising same
US20100158978A1 (en) * 2008-12-23 2010-06-24 Peter Markland Bioactive spray coating compositions and methods of making and uses thereof
US9415197B2 (en) 2008-12-23 2016-08-16 Surmodics, Inc. Implantable suction cup composites and implants comprising same
US8951546B2 (en) 2008-12-23 2015-02-10 Surmodics Pharmaceuticals, Inc. Flexible implantable composites and implants comprising same
EP2201935B1 (de) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymere Mizellenzusammensetzung, die ein schlecht lösliches Arzneimittel enthält, und zugehöriges Herstellungsverfahren
TWI374903B (en) * 2008-12-31 2012-10-21 Ind Tech Res Inst Biodegradable copolymer hydrogel materials
US20100203150A1 (en) * 2009-02-06 2010-08-12 National Tsing Hua University Novel amphiphilic copolymers and fabrication method thereof
CA2756072A1 (en) * 2009-03-30 2010-10-14 Cerulean Pharma Inc. Polymer-agent conjugates, particles, compositions, and related methods of use
WO2010114768A1 (en) * 2009-03-30 2010-10-07 Cerulean Pharma Inc. Polymer-epothilone conjugates, particles, compositions, and related methods of use
MX364947B (es) 2009-10-01 2019-05-15 Adare Pharmaceuticals Inc Composiciones de corticosteroides administradas oralmente.
DK2509634T3 (en) 2009-12-11 2019-04-23 Pfizer Stable formulations for lyophilization of therapeutic particles
EP2515942B1 (de) 2009-12-15 2020-02-12 Pfizer Inc. Therapeutische polymernanopartikelzusammensetzungen mit hoher glasübergangstemperatur oder copolymeren von hohem molekulargewicht
WO2011119995A2 (en) 2010-03-26 2011-09-29 Cerulean Pharma Inc. Formulations and methods of use
UA111162C2 (uk) 2010-08-04 2016-04-11 Флекшен Терап'Ютікс, Інк. Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
EP2611868B1 (de) 2010-08-30 2020-01-08 Surmodics Pharmaceuticals, Inc. Biologisch abbaubare terpolymere und terpolymermischungen als haftkleber
US9023897B2 (en) 2010-12-29 2015-05-05 Medincell Biodegradable drug delivery compositions
KR101723272B1 (ko) 2011-06-21 2017-04-18 비브이더블유 홀딩 에이쥐 보스웰릭산을 포함하는 메디컬 디바이스
WO2013148682A1 (en) * 2012-03-26 2013-10-03 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents
EP2866837B1 (de) * 2012-06-27 2022-12-14 Medincell S.A. Biologisch abbaubare wirkstofffreisetzung für hydrophobe zusammensetzungen
WO2014043618A1 (en) 2012-09-17 2014-03-20 Bind Therapeutics, Inc. Process for preparing therapeutic nanoparticles
US20150104520A1 (en) * 2013-04-05 2015-04-16 Vuong Trieu Nanoparticle Formulations in Biomarker Detection
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CN104758256B (zh) * 2014-02-14 2016-05-04 苏州海特比奥生物技术有限公司 一种多西他赛纳米聚合物胶束冻干制剂及其制备方法
PE20170312A1 (es) 2014-03-14 2017-03-30 Pfizer Nanoparticulas terapeuticas que comprenden un agente terapeutico, y metodos para su elaboracion y uso
MX382255B (es) * 2015-06-18 2025-03-13 Acuitybio Corp Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
US20200155449A1 (en) 2015-11-16 2020-05-21 Medincell Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
TWI728172B (zh) 2016-08-18 2021-05-21 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
CN106727306A (zh) * 2016-12-12 2017-05-31 温州医科大学 一种高载药量曲安奈德胶束的制备方法
CN107596380B (zh) * 2017-09-03 2020-09-11 河南师范大学 基于聚乙二醇-聚碳酸酯的还原敏感性喜树碱前药及其制备方法和应用
KR102072419B1 (ko) * 2018-04-19 2020-02-03 중앙대학교 산학협력단 항암제 봉입 마이셀 제제 조성물
CN115666621A (zh) 2020-01-13 2023-01-31 度勒科特公司 具有减少的杂质的持续释放药物递送系统及相关方法
BR112022020991A2 (pt) * 2020-08-31 2023-03-07 Vaim Co Ltd Dispersão de polímero biodegradável, composição compreendendo a mesma e sistema de melhoria da pele
KR102905790B1 (ko) * 2020-08-31 2026-01-08 주식회사 바임 생분해성 고분자 분산체, 이를 포함하는 조성물 및 피부 개선용 시스템
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
CN114903904B (zh) * 2021-02-08 2024-02-09 宜昌人福药业有限责任公司 瑞马唑仑药用盐和阿片样物质的注射用药物组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
DE69101291T2 (de) * 1990-08-30 1994-07-07 Senju Pharma Co Zusammensetzung zur kontrollierten Abgabe von Medikamenten.
US5543158A (en) * 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
JPH08176016A (ja) * 1994-12-19 1996-07-09 Univ Miami 生分解可能で注射可能な薬物運搬ポリマー
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US5702717A (en) * 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
US6004573A (en) 1997-10-03 1999-12-21 Macromed, Inc. Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
US20020164374A1 (en) * 1997-10-29 2002-11-07 John Jackson Polymeric systems for drug delivery and uses thereof
KR100289074B1 (ko) * 1998-02-04 2001-07-12 김윤 난용성약물함유시스템
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
KR100274842B1 (ko) * 1998-10-01 2001-03-02 김효근 미립구를 이용한 레티노익산의 서방형 약물방출 시스템
KR100360827B1 (ko) * 1999-08-14 2002-11-18 주식회사 삼양사 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법
CA2408548C (en) * 2000-05-12 2008-03-11 Samyang Corporation Method for the preparation of polymeric micelle via phase separation of block copolymer
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof

Also Published As

Publication number Publication date
AU2273302A (en) 2002-06-18
DE60135486D1 (de) 2008-10-02
KR20020045569A (ko) 2002-06-19
JP2004514734A (ja) 2004-05-20
WO2002045689A1 (en) 2002-06-13
US7153520B2 (en) 2006-12-26
EP1339389A1 (de) 2003-09-03
KR100446101B1 (ko) 2004-08-30
CA2430481A1 (en) 2002-06-13
CN1477952A (zh) 2004-02-25
EP1339389A4 (de) 2007-08-08
US20040037885A1 (en) 2004-02-26
EP1339389B1 (de) 2008-08-20
CN1234416C (zh) 2006-01-04
CA2430481C (en) 2008-07-22
AU2002222733B2 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
ATE405251T1 (de) Zusammensetzungen zur verzögerten abgabe von hydrophoben arzneimitteln und verfahren zu ihrer herstellung
ATE141788T1 (de) Mikrosphäre enthaltende pharmazeutische zusammensetzung mit kontrollierter freigabe und verfahren zur herstellung
EP0863933B1 (de) Hydrogele auf basis von dreiblockcopolymerisate, ihre herstellung und ihre verwendung
WO2004112748A3 (en) Rate controlled release of a pharmaceutical agent in a biodegradable device
DE60031286D1 (de) Polymere zusammensetzung zur lösung von schwer wasserlöslichen medikamenten und verfahren zu deren herstellung
WO2001091725A3 (en) Biologically useful polyphosphates
CY1109606T1 (el) Βιοδιασπωμενο υμενιο για την απελευθερωση φαρμακου στον οφθαλμο
AU3468900A (en) Cyclodextrin polymers for use as drug carriers
DK1126822T3 (da) Flydende tilförselspræparater med reguleret frigivelse og lav initiel lægemiddelafgivelse
CA2395077A1 (en) Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
CA2452806A1 (en) Water-soluble stabilized self-assembled polyelectrolytes
Overstreet et al. In situ forming, resorbable graft copolymer hydrogels providing controlled drug release
BRPI0510568A (pt) copolìmero, processo para preparação do mesmo, partìcula biodegradável, uso da mesma, processo para preparação de um sistema de liberação, composição para perfumar, e, produto perfumado
ATE468848T1 (de) In organischen lösemitteln lösliche biologisch abbaubare poly (alkylenoxid)- poly (p-dioxanon) blockcopolymere sowie diese enthaltende zusammensetzung zur arzneistoffverabreichung
BRPI0410956A (pt) pelìculas com base em óxido de polietileno e sistemas de liberação de droga feitos delas
CA2451187A1 (en) Zero-order prolonged release coaxial implants
EP1539109B1 (de) Blockcopolymer-mizellenzusammensetzung mit verbesserter arzneimittelbeladungskapazität und verzögerter freisetzung
BR9808933A (pt) Composição sob forma de microcápsulas ou de implantes, processo de preparação de uma substância hidrossolúvel, substância ativa, acetato de triptorelina, acetato de lanreotìdeo, ou acetato de octreotìdeo, e rna de filamento duplo
Loh et al. Biodegradable thermogelling polymers
WO2003037337A8 (en) Depot formulations of iloperidone and a star polymer
WO2004078111A3 (en) Extended release minocycline compositions and processes for their preparation
Jones et al. In situ forming biomaterials
WO2004018010A3 (en) Methods of drug delivery using sulphated chitinous polymers
AU2002353661A1 (en) Biodegradable polymeric material for biomedical applications
JP2014221732A (ja) 温度応答性生分解性高分子組成物及びその製造方法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties